Trial intelligence / Profile preview

Phase III trial of GB491 plus letrozole in previously untreated HR-positive/HER2-negative advanced or metastatic breast cancer

CTR20212139Phase 3Active

Sponsor

G1 Therapeutics, Inc.

Start

Jan 2022

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1